Céline Dogan

MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1

Michael Flower, Vilija Lomeikaite, Marc Ciosi et al. · Brain · 2019 · 169 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study

Céline Dogan, Marie De Antonio, Dalil Hamroun et al. · PLoS ONE · 2016 · 148 citations · Full text

Medicine, Genetics, Internal Medicine +15

Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial

Kees Okkersen, Cecilia Jimenez‐Moreno, Stephan Wenninger et al. · The Lancet Neurology · 2018 · 121 citations · Full text

Medicine, Rehabilitation Medicine, Physical Activity +11

A large multicenter study of pediatric myotonic dystrophy type 1 for evidence-based management

Emmanuelle Lagrue, Céline Dogan, Marie De Antonio et al. · Neurology · 2019 · 73 citations

Medicine, Child Health, Pediatrics +9

Unusual association of a unique CAG interruption in 5′ of DM1 CTG repeats with intergenerational contractions and low somatic mosaicism

Stéphanie Tomé, Elodie Dandelot, Céline Dogan et al. · Human Mutation · 2018 · 41 citations

Life Sciences, Genetics, Molecular Genetics +15